pulse , a diagnostic development company whose aim is to improve neonatal screening has raised $ 13 million in seed funding . The main investors include : Duke University , discovery labs , Triad and the Duke Angel Network . Baebies is developing a screening platform that employs microfluidics , and consists of a bench - top analyser and software that runs tests on samples in digital microfluidic cartridges .
Baebies, a diagnostic development company whose aim is to improve neonatal screening has raised $13 million in equity financing. The main investors included: Duke University, Cunning Capital, Triad and the Duke Angel Network. Baebies is developing a screening platform that employs microfluidics, and consists of a bench-top analyser and software that runs tests on samples in digital microfluidic cartridges.